Filing Details
- Accession Number:
- 0000917520-24-000023
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-08 16:22:26
- Reporting Period:
- 2024-03-06
- Accepted Time:
- 2024-03-08 16:22:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 917520 | Integra Lifesciences Holdings Corp | IART | Surgical & Medical Instruments & Apparatus (3841) | 510317849 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1563606 | Jr. T. Robert Davis | 1100 Campus Road Princeton NJ 08540 | Evp & President, Tt | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-06 | 8,736 | $32.59 | 58,241 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-06 | 8,348 | $36.59 | 49,893 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-03-06 | 8,736 | $0.00 | 8,736 | $32.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-03-14 | No | 4 | M | Direct |
Footnotes
- Represents shares sold in connection with a broker-assisted "sell to cover" cashless exercise transaction to cover the exercise price and withholding taxes upon the exercise of stock options scheduled to expire.
- The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $36.57 to $36.65 The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- 25% of the stock options vested on the first, second, third and fourth anniversary of the original grant date of March 14, 2016.
Billionaire Hedge Funds
